cerca CERCA
Giovedì 25 Aprile 2024
Aggiornato: 17:12
10 ultim'ora BREAKING NEWS

CHIMICA E FARMACEUTICA

Steriline - Isolatori e Robotica al centro della filosofia zero sprechi

Steriline al CPhI di Barcellona 2023 con la RVCM2 “zero sprechi”

Como 10/10/2023 - Steriline sarà presente all’annuale edizione del CPhI, quest’anno a Barcellona, in programma tra il 24 e il 26 ottobre. L’occasione è ideale per riaffermare ancora una volta la filosofia "zero sprechi" che da anni alimenta gli investimenti in ricerca e sviluppo di nuovi prodotti dell’azienda comasca, leader nel settore del confezionamento primario per l’industria farmaceutica.

comunicato stampa

Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial

NAPERVILLE, Ill., Oct. 9, 2023 /PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational Device Exemption (IDE) approval from the FDA for a subsequent multicenter study, PROACTIVE-HF 2, which will evaluate the company's Cordella Sensor for pulmonary artery (PA) pressure-guided therapy. The prospective, dual-arm trial aims to expand access to New York Heart Association (NYH...

comunicato stampa

Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds

FORT COLLINS, Colo., Oct. 4, 2023 /PRNewswire/ -- Armis Biopharma, Inc. announced today that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop its proprietary Veriox® DECON chemical warfare agent (CWA) decontamination product for use in battlefield wounds. This will be an important product for warfighters who may be exposed to chemical warfare agents when wounded as the technology could have the potential to help save lives and extend the opp...

comunicato stampa

Armis Biopharma annuncia di aver ricevuto un contratto da 20,3 milioni di dollari dalla Defense Threat Reduction Agency per lo sviluppo di Veriox® DECON per le ferite sul campo di battaglia

FORT COLLINS, Colorado, 4 ottobre 2023 /PRNewswire/ -- Armis Biopharma, Inc. ha annunciato oggi di aver ricevuto un contratto da 20,3 milioni di dollari dalla Defense Threat Reduction Agency (DTRA) per lo sviluppo del prodotto di decontaminazione da agenti di guerra chimica (CWA) Veriox® DECON, di sua proprietà, da utilizzare per le ferite sul campo di battaglia. Si tratta di un prodotto importante per i combattenti che possono essere esposti ad agenti di guerra chimica quando sono feriti, in qua...

comunicato stampa

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

EAST RUTHERFORD, N.J, Oct. 2, 2023 /PRNewswire/ -- Cambrex today announced the completion of its $38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. This expansion doubles the facility's manufacturing capacity, with new state-of-the-art analytical and chemical development laboratories, two new clinical manufacturing suites, and a small-scale commercial manufacturing operation with three work centers and ...

comunicato stampa

LyondellBasell Demonstrates Commitment to Sustainability with Launch of +LC (Low Carbon) Solutions

HOUSTON, Sept. 26, 2023 /PRNewswire/ -- LyondellBasell today announced the expansion of its sustainable offerings with the launch of its +LC (Low Carbon) solutions, a new range of Intermediates and Derivatives (I&D) chemicals produced under an International Sustainability and Carbon Certification (ISCC) PLUS certified mass balance methodology. Sourced from recycled and renewable feedstocks, these +LC solutions are designed to support businesses in meeting their greenhouse gas (GHG) emissions redu...

comunicato stampa

The 88th CMEF in Shenzhen Set to Spotlight Advancements in the Medical Equipment Industry

SHENZHEN, China, Sept. 25, 2023 /PRNewswire/ -- The China International Medical Equipment Fair (CMEF), organized by Reed Sinopharm Exhibitions, serves as an excellent bridge for brands aiming to enter the Chinese market. The 88th edition of this prestigious medical event is scheduled to take place from October 28 to 31 at the Shenzhen World Exhibition & Convention Center. These exhibitors will showcase cutting-edge products and solutions to meet the significant demands in the Chinese market.

comunicato stampa

Seegene rivela "Open Innovation Program Powered by Seegene" in collaborazione con Springer Nature

SEUL, Corea del Sud, 13 settembre 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), azienda leader nella Corea del Sud che fornisce una soluzione totale per la diagnostica molecolare PCR, ha presentato oggi il suo "Open Innovation Program powered by Seegene (Open Innovation Program)" in collaborazione con Springer Nature, uno dei principali fornitori di servizi alla comunità di ricerca. Il programma inaugurale è disponibile a livello globale e rappresenta il primo passo per consentire a esperti, scie...

comunicato stampa

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment of Saulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience and a unique blend of leadership, operational expertise, and a deep understanding of manufacturing operational excellence and supply chain.

comunicato stampa

LyondellBasell Named in U.S. News & World Report's 2023-2024 Best Companies to Work For List

HOUSTON and LONDON, Sept. 7, 2023 /PRNewswire/ -- LyondellBasell today announced it has been named as one of the Best Companies to Work For in the U.S. News & World Report2023-2024 rankings. LyondellBasell was compared to 200 companies and was evaluated based on how well the company met expectations important to job seekers in finding a workplace that aligns with their needs.

comunicato stampa

CXV Global and Panacea Technologies Announce New Name

CORK, Ireland and PHILADELPHIA, Sept. 6, 2023 /PRNewswire/ -- CXV Global and Panacea Technologies today announced their new name, Catalyx, to reflect their united purpose and offering focused on optimizing operations for organizations in life sciences and other highly regulated industries.



SEGUICI SUI SOCIAL



threads whatsapp linkedin twitter youtube facebook instagram
ora in
Prima pagina
articoli
in Evidenza